SIMPLAAFY Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1857 participants.
Also called NCT06521463
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 1,857 participants
- Sponsor
- Registry
-
NCT06521463
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06521463. Randomized; single masking; primary purpose prevention. Start 2024-10-01 (actual); primary completion 2026-07-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SIMPLAAFY Clinical Trial
- Acronym
- SIMPLAAFY
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Condition
- Bleeding
- Intervention (Device)
- WATCHMAN FLX Pro LAAC Device
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct06521463- Content hash
d2532d46d52255e89120b6b3d78613b03408c0f9b63005d53b6643cc1da4fb11